Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Massimo Breccia
Obesity Is a Risk Factor for Acute Promyelocytic Leukemia: Evidence From Population and Cross-Sectional Studies Studies and Correlation With Flt3 Mutations and Polyunsaturated Fatty Acid Metabolism
Haematologica
Hematology
The Eutos Long-Term Survival Score (Elts) Accurately Predicts the Risk of Death in Chronic Myeloid Leukaemia Patients Treated Outside of Clinical Trials
American Journal of Hematology
Hematology
Italian Survey on Clinical Practice in Myeloproliferative Neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party Initiative
American Journal of Hematology
Hematology
Chronic Myeloid Leukaemia With Extreme Thrombocytosis at Presentation: Incidence, Clinical Findings and Outcome
British Journal of Haematology
Hematology
Safety and Efficacy of Ruxolitinib in Myelofibrosis Patients Without Splenomegaly
British Journal of Haematology
Hematology
Long-Term Impact of Molecular Response Fluctuations in Chronic Myeloid Leukaemia Patients Treated With Imatinib
British Journal of Haematology
Hematology
Prognostic Factors Associated With a Stable MR4.5 Achievement in Chronic Myeloid Leukemia Patients Treated With Imatinib
Oncotarget
Oncology
Current Information and Recommendations on the Discontinuation of TKI Inhibitors in Chronic Myeloid Leukemia
Current Oncology Reports
Oncology
How Many Chronic Myeloid Leukemia Patients Who Started a Frontline Second‐generation Tyrosine Kinase Inhibitor Have to Switch to a Second‐line Treatment? A Retrospective Analysis From the Monitoring Registries of the Italian Medicines Agency (AIFA)
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Imatinib Improved the Overall Survival of Chronic Myeloid Leukemia Patients in Low- And Middle-Income Countries: A Therapeutic Goal Has Been Reached
EClinicalMedicine
Medicine
1
2
›
